Bone/collagen composites and uses thereof
View Patent ↗A composition includes bone and collagen, wherein the collagen has been acid treated, and cross-linked via dehydrothermal treatment or by a cross-linking agent (e.g., a citric acid derivative) under a compressive force of at least approximately 40 MPa.
1. A composition comprising:
approximately 10% to approximately 50% by weight of pressure treated collagen, wherein the pressure treated collagen is cross-linked using a citric acid derivative under a compressive force of at least approximately 40 MPa, and the composition is load bearing and has a wet compressive strength of from about 7 MPa to about 52 MPa;
harvested bone including a linker configured to facilitate interactions with the pressure treated collagen; and
the citric acid derivative.
2. The composition of claim 1 , wherein the compressive force ranges from approximately 40 MPa to approximately 275 MPa.
3. The composition of claim 1 , wherein a visible band structure of collagen fibers is preserved.
4. The composition of claim 1 , wherein the pressure treated collagen comprises mammalian collagen.
5. The composition of claim 1 , wherein the pressure treated collagen comprises bovine or porcine collagen.
6. The composition of claim 1 , wherein the pressure treated collagen comprises human collagen.
7. The composition of claim 1 , comprising approximately 20% to approximately 40% by weight of pressure treated collagen.
8. The composition of claim 1 , comprising approximately 30% by weight of pressure treated collagen.
9. The composition of claim 1 , comprising approximately 50% to approximately 90% by weight of harvested bone.
10. The composition of claim 1 , comprising approximately 60% to approximately 80% by weight of harvested bone.
11. The composition of claim 1 , comprising approximately 70% by weight of harvested bone.
12. The composition of claim 1 , further comprising hydroxyapatite.
13. The composition of claim 1 , further comprising an inorganic bone substitute material.
14. The composition of claim 1 , wherein the citric acid derivative comprises N-hydroxysuccinimide modified citric acid.
15. The composition of claim 1 , further comprising latent pores.
16. The composition of claim 15 , wherein the latent pores comprise dextran and upon implantation of the composition to a surgical site the dextran dissolves leaving behind pores exhibiting a hemostatic property.
17. The composition of claim 1 , wherein the harvested bone comprises bone shards having a particle size of about 10 microns to about 1000 microns.
18. A composition comprising bone particles and approximately 10% to approximately 50% by weight of pressure treated collagen, the bone particles comprising a linker configured to facilitate interactions with the pressure treated collagen, the composition being load bearing and having a wet compressive strength of from about 7 MPa to about 52 MPa, wherein the composition is prepared by adding bone particles to a dispersion of pressure treated collagen at an acidic pH ranging from approximately 3 to approximately 6;
applying a compressive force at least approximately 40 MPa; and cross-linking the pressure treated collagen using a citric acid derivative, the composition further comprising the citric acid derivative.